Lebwohl M - Search Results

1

An investigator-initiated, double-blind, vehicle-controlled pilot study: assessment for tachyphylaxis to topically occluded halobetasol 0.05% ointment in the treatment of psoriasis.

Czarnowicki T, Linkner RV, Suárez-Fariñas M, Ingber A, Lebwohl M. Czarnowicki T, et al. Among authors: lebwohl m. J Am Acad Dermatol. 2014 Nov;71(5):954-959.e1. doi: 10.1016/j.jaad.2014.05.040. Epub 2014 Jun 11. J Am Acad Dermatol. 2014. PMID: 24929883 Clinical Trial.

2

A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis.

Olsen EA, Cram DL, Ellis CN, Hickman JG, Jacobson C, Jenkins EE, Lasser AE, Lebwohl M, Leibsohn E, Medansky RS, et al. Olsen EA, et al. Among authors: lebwohl m. J Am Acad Dermatol. 1991 Mar;24(3):443-7. doi: 10.1016/0190-9622(91)70069-e. J Am Acad Dermatol. 1991. PMID: 2061442 Clinical Trial.

3

Effects of topical preparations on the erythemogenicity of UVB: implications for psoriasis phototherapy.

Lebwohl M, Martinez J, Weber P, DeLuca R. Lebwohl M, et al. J Am Acad Dermatol. 1995 Mar;32(3):469-71. doi: 10.1016/0190-9622(95)90071-3. J Am Acad Dermatol. 1995. PMID: 7868718

4

Pemphigus vulgaris after initiation of psoralen and UVA therapy for psoriasis.

Fryer EJ, Lebwohl M. Fryer EJ, et al. Among authors: lebwohl m. J Am Acad Dermatol. 1994 Apr;30(4):651-3. doi: 10.1016/s0190-9622(09)80116-3. J Am Acad Dermatol. 1994. PMID: 8157795 No abstract available.

5

Topical therapy for psoriasis.

Lebwohl M, Abel E, Zanolli M, Koo J, Drake L. Lebwohl M, et al. Int J Dermatol. 1995 Oct;34(10):673-84. Int J Dermatol. 1995. PMID: 8537153 Review. No abstract available.

6

Infectious complications of erythrodermic psoriasis.

Green MS, Prystowsky JH, Cohen SR, Cohen JI, Lebwohl MG. Green MS, et al. Among authors: lebwohl mg. J Am Acad Dermatol. 1996 May;34(5 Pt 2):911-4. doi: 10.1016/s0190-9622(96)90078-x. J Am Acad Dermatol. 1996. PMID: 8621827

7

Efficacy and safety of fluticasone propionate ointment, 0.005%, in the treatment of eczema.

Lebwohl M. Lebwohl M. Cutis. 1996 Feb;57(2 Suppl):62-8. Cutis. 1996. PMID: 8646873 Clinical Trial.

8

A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.

Lebwohl M, Siskin SB, Epinette W, Breneman D, Funicella T, Kalb R, Moore J. Lebwohl M, et al. J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):268-9. doi: 10.1016/s0190-9622(96)90349-7. J Am Acad Dermatol. 1996. PMID: 8708035 Clinical Trial. No abstract available.

9

Topical calcipotriene in combination with UVB phototherapy for psoriasis.

Hecker D, Lebwohl M. Hecker D, et al. Among authors: lebwohl m. Int J Dermatol. 1997 Apr;36(4):302-3. doi: 10.1046/j.1365-4362.1997.00203.x. Int J Dermatol. 1997. PMID: 9169336 Clinical Trial.

10

Interactions between calcipotriene and ultraviolet light.

Lebwohl M, Hecker D, Martinez J, Sapadin A, Patel B. Lebwohl M, et al. J Am Acad Dermatol. 1997 Jul;37(1):93-5. doi: 10.1016/s0190-9622(97)70217-2. J Am Acad Dermatol. 1997. PMID: 9216529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

753 results

Search Page

Filters